• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies.

作者信息

Hollenbeck C B, Coulston A M, Quan R, Becker T R, Vreman H J, Stevenson D K, Reaven G M

出版信息

Am J Clin Nutr. 1983 Oct;38(4):498-503. doi: 10.1093/ajcn/38.4.498.

DOI:10.1093/ajcn/38.4.498
PMID:6414283
Abstract

We have tested the effectiveness of a commercial starch blocker on the digestion and absorption of dietary carbohydrates in six normal, healthy volunteers. The effectiveness of the starch blocker to attenuate or block the digestion of carbohydrate was assessed against a placebo by the measurement of end tidal breath hydrogen, plasma glucose, and insulin responses to a constant test meal. There were no significant differences in breath hydrogen, or plasma glucose and insulin responses. In vitro enzyme inhibition studies assessed the ability of the brush border enzyme maltase/glucoamylase to degrade starch in the presence of the starch blockers. A highly purified solution of rat and human maltase/glucoamylase was capable of degrading a starch solution, while 40 mM Tris-HCl (a known maltase/glucoamylase inhibitor) completely abolished the enzyme activity. These data challenge the claims that starch blocker preparations are effective in reducing or attenuating the absorption of carbohydrates or calories from a mixed meal. The ineffectiveness in vivo could be explained, in part, by the ability of the brush border enzyme maltase/glucoamylase to hydrolyze starch in the presence of starch blockers.

摘要

相似文献

1
Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies.
Am J Clin Nutr. 1983 Oct;38(4):498-503. doi: 10.1093/ajcn/38.4.498.
2
A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man.一种豆类α淀粉酶抑制剂制剂(淀粉阻滞剂)对人体无效。
Science. 1983 Jan 28;219(4583):393-5. doi: 10.1126/science.6184780.
3
Starch blockers--their effect on calorie absorption from a high-starch meal.淀粉阻滞剂——它们对高淀粉餐中热量吸收的影响。
N Engl J Med. 1982 Dec 2;307(23):1413-6. doi: 10.1056/NEJM198212023072301.
4
Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus.纯化淀粉酶抑制剂对正常受试者及糖尿病患者碳水化合物耐量的影响。
Mayo Clin Proc. 1986 Jun;61(6):442-7. doi: 10.1016/s0025-6196(12)61978-8.
5
Starch blockers--still no calorie-free lunch.
N Engl J Med. 1982 Dec 2;307(23):1444-5. doi: 10.1056/NEJM198212023072309.
6
The Postprandial Anti-Hyperglycemic Effect of Pyridoxine and Its Derivatives Using In Vitro and In Vivo Animal Models.吡哆醇及其衍生物在体外和体内动物模型中的抗餐后高血糖作用。
Nutrients. 2018 Feb 28;10(3):285. doi: 10.3390/nu10030285.
7
Pasta cooking time: influence on starch digestion and plasma glucose and insulin responses in healthy subjects.意大利面烹饪时间:对健康受试者淀粉消化、血糖及胰岛素反应的影响
Am J Clin Nutr. 1990 Mar;51(3):421-7. doi: 10.1093/ajcn/51.3.421.
8
The effect of starch-protein interaction in wheat on the glycemic response and rate of in vitro digestion.小麦中淀粉-蛋白质相互作用对血糖反应及体外消化率的影响。
Am J Clin Nutr. 1987 May;45(5):946-51. doi: 10.1093/ajcn/45.5.946.
9
Starch digestion and absorption in nonruminants.非反刍动物的淀粉消化与吸收
J Nutr. 1992 Jan;122(1):172-7. doi: 10.1093/jn/122.1.172.
10
Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test.通过氢呼气试验评估抗性淀粉的肠道转运和发酵。
Eur J Clin Nutr. 1994 Oct;48(10):692-701.

引用本文的文献

1
Common bean (Phaseolus vulgaris L.) α-amylase inhibitors as safe nutraceutical strategy against diabetes and obesity: An update review.普通菜豆(Phaseolus vulgaris L.)α-淀粉酶抑制剂作为防治糖尿病和肥胖的安全营养策略:最新综述。
Phytother Res. 2022 Jul;36(7):2803-2823. doi: 10.1002/ptr.7480. Epub 2022 Apr 29.
2
Heterologous expression of an α-amylase inhibitor from common bean (Phaseolus vulgaris) in Kluyveromyces lactis and Saccharomyces cerevisiae.菜豆(Phaseolus vulgaris)α-淀粉酶抑制剂在乳酸克鲁维酵母和酿酒酵母中的异源表达。
Microb Cell Fact. 2017 Jun 15;16(1):110. doi: 10.1186/s12934-017-0719-4.
3
ZnO nanoparticles and their acarbose-capped nanohybrids as inhibitors for human salivary amylase.
氧化锌纳米颗粒及其阿卡波糖封端的纳米杂化物作为人唾液淀粉酶的抑制剂
IET Nanobiotechnol. 2017 Apr;11(3):329-335. doi: 10.1049/iet-nbt.2016.0115.
4
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.脂质和碳水化合物消化酶抑制剂在肥胖管理中的作用:当前和新兴治疗药物的综述。
Diabetes Metab Syndr Obes. 2010 May 10;3:125-43. doi: 10.2147/dmsott.s7005.
5
Commercial soybean starch blocker consumption: impact on weight gain and on copper, lead and zinc status of rats.食用商业大豆淀粉阻滞剂:对大鼠体重增加以及铜、铅和锌状态的影响。
Plant Foods Hum Nutr. 1992 Apr;42(2):135-42. doi: 10.1007/BF02196466.